These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 10846424

  • 21. Transient cranial neuropathy in prostatic cancer with bone metastases after rhenium-186-HEDP treatment.
    de Klerk JM, Zonnenberg BA, Krouwer HG, Blijham GH, van Dijk A, van het Schip AD, van Die J, van Rijk PP.
    J Nucl Med; 1996 Mar; 37(3):465-7. PubMed ID: 8772646
    [Abstract] [Full Text] [Related]

  • 22. Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
    Liepe K, Kropp J, Hliscs R, Franke WG.
    Clin Nucl Med; 2000 Nov; 25(11):901-4. PubMed ID: 11079588
    [Abstract] [Full Text] [Related]

  • 23. Palliative therapy with rhenium-186-HEDP for bone metastases of breast cancer.
    Guerra UP, Englaro E, Cattaruzzi E.
    Tumori; 1997 Nov; 83(2):560-2. PubMed ID: 9226021
    [No Abstract] [Full Text] [Related]

  • 24. Palliative therapy using rhenium-186-HEDP in painful breast osseous metastases.
    Limouris GS, Shukla SK, Condi-Paphiti A, Gennatas C, Kouvaris I, Vitoratos N, Manetou A, Dardoufas C, Rigas V, Vlahos L.
    Anticancer Res; 1997 Nov; 17(3B):1767-72. PubMed ID: 9179232
    [Abstract] [Full Text] [Related]

  • 25. Treatment of metastatic bone pain using the bone seeking radiopharmaceutical Re-186-HEDP.
    De Klerk JM, Zonnenberg BA, Blijham GH, Van Het Schip AD, Hoekstra A, Han SH, Quirijnen JM, Van Dijk A, Van Rijk PP.
    Anticancer Res; 1997 Nov; 17(3B):1773-7. PubMed ID: 9179233
    [Abstract] [Full Text] [Related]

  • 26. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
    Liepe K, Kotzerke J.
    Nucl Med Commun; 2007 Aug; 28(8):623-30. PubMed ID: 17625384
    [Abstract] [Full Text] [Related]

  • 27. [Pain therapy with rhenium-186 HEDP in multiple bone metastases].
    Palmedo H, Bender H, Schomburg A, Grünwald F, Schöneich G, Zamorra P, Reichmann K, Dierke-Dzierzon C, Mallmann P, Biersack HJ.
    Nuklearmedizin; 1996 Apr; 35(2):63-7. PubMed ID: 8721578
    [Abstract] [Full Text] [Related]

  • 28. Rhenium-186-HEDP palliative treatment in disseminated bone metastases due to prostate cancer.
    Limouris G, Shukla SK, Manetou A, Kouvaris I, Plataniotis G, Triantafyllou N, Rigas AV, Vlahos L.
    Anticancer Res; 1997 Apr; 17(3B):1699-704. PubMed ID: 9179222
    [Abstract] [Full Text] [Related]

  • 29. Treatment of painful bone metastases in prostate and breast cancer patients with the therapeutic radiopharmaceutical rhenium-188-HEDP. Clinical benefit in a real-world study.
    Lange R, Overbeek F, de Klerk JM, Pasker-de Jong PC, van den Berk AM, Ter Heine R, Rodenburg CJ, Kooistra A, Hendrikse NH, Bloemendal HJ.
    Nuklearmedizin; 2016 Sep 26; 55(5):188-95. PubMed ID: 27443809
    [Abstract] [Full Text] [Related]

  • 30. Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients.
    Zhang H, Tian M, Li S, Liu J, Tanada S, Endo K.
    Cancer Biother Radiopharm; 2003 Oct 26; 18(5):719-26. PubMed ID: 14629820
    [Abstract] [Full Text] [Related]

  • 31. Rhenium-188 hydroxyethylidene diphosphonate: a new generator-produced radiotherapeutic drug of potential value for the treatment of bone metastases.
    Lin WY, Lin CP, Yeh SJ, Hsieh BT, Tsai ZT, Ting G, Yen TC, Wang SJ, Knapp FF, Stabin MG.
    Eur J Nucl Med; 1997 Jun 26; 24(6):590-5. PubMed ID: 9169563
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of thrombocytopenia in patients treated with rhenium-186-HEDP: guidelines for individual dosage recommendations.
    de Klerk JM, van het Schip AD, Zonnenberg BA, van Dijk A, Stokkel MP, Han SH, Blijham GH, van Rijk PP.
    J Nucl Med; 1994 Sep 26; 35(9):1423-8. PubMed ID: 8071686
    [Abstract] [Full Text] [Related]

  • 33. Remission of bone metastases after combined chemotherapy and radionuclide therapy with Re-186 HEDP.
    Palmedo H, Grünwald F, Wagner U, Köhler S, Krebs D, Biersack HJ.
    Clin Nucl Med; 1998 Aug 26; 23(8):501-4. PubMed ID: 9712380
    [Abstract] [Full Text] [Related]

  • 34. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
    Minutoli F, Herberg A, Spadaro P, Restifo Pecorella G, Baldari S, Aricò D, Altavilla G, Baldari S.
    Q J Nucl Med Mol Imaging; 2006 Dec 26; 50(4):355-62. PubMed ID: 17043634
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of rhenium-186 after administration of rhenium-186-HEDP to patients with bone metastases.
    de Klerk JM, van Dijk A, van het Schip AD, Zonnenberg BA, van Rijk PP.
    J Nucl Med; 1992 May 26; 33(5):646-51. PubMed ID: 1373767
    [Abstract] [Full Text] [Related]

  • 36. Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases.
    Palmedo H, Guhlke S, Bender H, Sartor J, Schoeneich G, Risse J, Grünwald F, Knapp FF, Biersack HJ.
    Eur J Nucl Med; 2000 Feb 26; 27(2):123-30. PubMed ID: 10755716
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of toxicity and efficacy of 186Re-hydroxyethylidene diphosphonate in patients with painful bone metastases of prostate or breast cancer.
    Kolesnikov-Gauthier H, Carpentier P, Depreux P, Vennin P, Caty A, Sulman C.
    J Nucl Med; 2000 Oct 26; 41(10):1689-94. PubMed ID: 11037999
    [Abstract] [Full Text] [Related]

  • 38. Repeated bone-targeted therapy for hormone-refractory prostate carcinoma: tandomized phase II trial with the new, high-energy radiopharmaceutical rhenium-188 hydroxyethylidenediphosphonate.
    Palmedo H, Manka-Waluch A, Albers P, Schmidt-Wolf IG, Reinhardt M, Ezziddin S, Joe A, Roedel R, Fimmers R, Knapp FF, Guhlke S, Biersack HJ.
    J Clin Oncol; 2003 Aug 01; 21(15):2869-75. PubMed ID: 12885803
    [Abstract] [Full Text] [Related]

  • 39. Rhenium-186 hydroxyethylidene diphosphonate for treatment of painful osseous metastases from mammary carcinoma.
    Virotta G, Medolago G, Arrigoni S, Butti I, Bertocchi C.
    Tumori; 1997 Aug 01; 83(2):563-5. PubMed ID: 9226022
    [No Abstract] [Full Text] [Related]

  • 40. Rhenium-186(Sn)HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.
    Maxon HR, Schroder LE, Hertzberg VS, Thomas SR, Englaro EE, Samaratunga R, Smith H, Moulton JS, Williams CC, Ehrhardt GJ.
    J Nucl Med; 1991 Oct 01; 32(10):1877-81. PubMed ID: 1717669
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.